Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Bluefish Pharmaceuticals AB (publ)

Closing information (x1000 DKK)

Closing information 2025/04 (consolidated) 2024/04 (consolidated) 2023/04 (consolidated)
Turnover 339,714 Less Arrow 307,634 More Arrow 355,527
Financial expenses 21,775 Less Arrow 18,697 More Arrow 27,090
Earnings before taxes 3,573 More Arrow 20,672 Less Arrow -59,356
EBITDA 9,976 More Arrow 30,187 Less Arrow -18,131
Total assets 404,641 Less Arrow 373,710 Less Arrow 355,936
Current assets 310,105 Less Arrow 293,896 Less Arrow 270,829
Current liabilities 349,245 Less Arrow 192,666 Less Arrow 133,358
Equity capital 43,350 Less Arrow 28,554 Less Arrow -27,416
- share capital 14,684 Less Arrow 13,697 More Arrow 14,208
Employees (average) 122 More Arrow 126 More Arrow 128

Financial ratios

Fiscal year 2025/04 (consolidated) 2024/04 (consolidated) 2023/04 (consolidated)
Solvency 10.7% Less Arrow 7.6% Less Arrow -7.7%
Turnover per employee 2,785 Less Arrow 2,442 More Arrow 2,778
Profit as a percentage of turnover 1.1% More Arrow 6.7% Less Arrow -16.7%
Return on assets (ROA) 6.3% More Arrow 10.5% Less Arrow -9.1%
Current ratio 88.8% More Arrow 152.5% More Arrow 203.1%
Return on equity (ROE) 8.2% More Arrow 72.4% More Arrow 216.5%
Change turnover 9,933 Less Arrow -35,105 More Arrow 101,766
Change turnover % 3% Less Arrow -10% More Arrow 40%
Chg. No. of employees -4 More Arrow -2 More Arrow 4
Chg. No. of employees % -3% More Arrow -2% More Arrow 3%

Total value of public sale

Fiscal year 2025/04 (consolidated) 2024/04 (consolidated) 2023/04 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.